Status:
COMPLETED
BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
Lead Sponsor:
BlueSky Immunotherapies GmbH
Conditions:
Safety Issues
HPV Infection
Eligibility:
All Genders
Brief Summary
This is a follow-up study for patients treated with FluBHPVE6E7 in previous interventional studies.
Detailed Description
BS-FU01 is a follow-up study for patients treated with FluBHPVE6E7 in previous phase 1 and 2 interventional studies. The aim of the follow-up study is to assess the safety and immunogenicity of FluBHP...
Eligibility Criteria
Inclusion
- Patient who enrolled in previous phase 1 or 2 clinical studies of FluBHPVE6E7
- Negative pregnancy test at baseline
- Written informed consent
Exclusion
- Pregnancy, breastfeeding
Key Trial Info
Start Date :
April 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04528407
Start Date
April 9 2021
End Date
January 31 2025
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vienna
Vienna, Austria, 1090